This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US FTC contends Edwards sped prior merger as it negotiated JenaValve deal

By Wesley Brown ( November 22, 2025, 00:12 GMT | Insight) -- JC Medical and its parent company, Genisis Medtech, were “all aligned in avoiding" the government notification process for JC Medical's acquisition by Edwards Lifesciences, according to an internal text submitted by the US Federal Trade Commission to a federal court. The FTC contends the companies avoided the Hart-Scott-Rodino notification process to speed the merger to get it done before Edwards acquired JenaValve.JC Medical and its parent company, Genisis Medtech, were “all aligned in avoiding" the government notification process for JC Medical's acquisition by Edwards Lifesciences, according to an internal text submitted by the US Federal Trade Commission to a federal court on Friday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login